Skip to main content
Category

Cancer

BrainCancerCancerDisease AreaLabMedia ReleasesMelanoma DiscoveryMelonomaNews & EventsResearchResearch AreaSystems Biology and Genomics

Lowering cancer drug dose could open tumours to immunotherapy

By | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and Genomics

Groundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…

CancerCancerFundingImmunotherapyLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsResearch

Predicting immunotherapy effectiveness in late-stage liver cancer

By | Cancer, Cancer, Funding, Immunotherapy, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research

Blood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…